Details for New Drug Application (NDA): 210955
✉ Email this page to a colleague
NDA 210955 describes NADOLOL, which is a drug marketed by Alembic, Amneal Pharms Co, Aurobindo Pharma, Beximco Pharms Usa, Chartwell Rx, Heritage Pharma, Invagen Pharms, Novast Labs, Rising, Rk Pharma, Sandoz, Teva Pharms, Zydus Pharms, Impax Labs, and Natco Pharma, and is included in sixteen NDAs. It is available from sixteen suppliers. Additional details are available on the NADOLOL profile page.
The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
Summary for 210955
| Tradename: | NADOLOL |
| Applicant: | Beximco Pharms Usa |
| Ingredient: | nadolol |
| Patents: | 0 |
Pharmacology for NDA: 210955
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 210955
Suppliers and Packaging for NDA: 210955
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NADOLOL | nadolol | TABLET;ORAL | 210955 | ANDA | Marlex Pharmaceuticals Inc | 10135-686 | 10135-686-01 | 100 TABLET in 1 BOTTLE (10135-686-01) |
| NADOLOL | nadolol | TABLET;ORAL | 210955 | ANDA | Marlex Pharmaceuticals Inc | 10135-687 | 10135-687-01 | 100 TABLET in 1 BOTTLE (10135-687-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
| Approval Date: | Jul 23, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Jul 23, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
| Approval Date: | Jul 23, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
